In December 2015, the Patented Medicine Prices Review Board (PMPRB) posted a Notice and Comment seeking stakeholder comments on ... Read More
Events
24
Mar2016
24
Mar2016
Ontario’s CED Will No Longer Routinely Evaluate CDR- or pCODR-Reviewed Drug Products
/ CDR, Ontario, pCODR, What's New
Effective April 1, 2016, all drug products reviewed by the Common Drug Review (CDR) and the pan-Canadian Oncology Drug Review ... Read More
15
Mar2016
The Ontario Public Drug Programs (OPDP) began funding INFLECTRA™ (infliximab) as a Limited Use (LU) benefit for eligible ODB recipients, ... Read More
15
Mar2016
The Canadian Agency for Drugs and Technologies in Health (CADTH) posted a call for patient input on March 11, ... Read More
10
Mar2016
The Canadian Agency for Drugs and Technologies in Health (CADTH) posted a call for patient input on March 9, ... Read More
10
Mar2016
The Ontario Ministry of Health and Long-Term Care (the ‘ministry’) is proposing to update recipient cost-sharing arrangements for non-low income ... Read More
26
Feb2016
Revised Procedures for CDR and pCODR
For all drug applications filed for review through either the Common Drug Review (CDR) or ... Read More
23
Feb2016
pCPA February Update – Federal Drug Plans officially join the pCPA and the full Office team is now in place
/ Canada, News, pCPA, What's New
In a recent update released to their website, the pan-Canadian Pharmaceutical Alliance (pCPA) announced 2 significant developments:
The Federal Drug ... Read More